Renoprotection in diabetes: genetic and non-genetic risk factors and treatment.
Steno Diabetes Center, Gentofte, Denmark.
H H
HH
Parving
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000235:genetics / Q000503:physiopathology* / Q000517:prevention & control* / Q000628:therapy; D018450:Disease Progression; D005919:Glomerular Filtration Rate; D006801:Humans; D007676:Kidney Failure, Chronic / Q000503:physiopathology / Q000517:prevention & control; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril